MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results
(NASDAQ: INKT) Delayed: 12.25 +0.20 (1.66%)
Previous Close $12.05    52 Week High $ 
Open $11.84    52 Week Low $ 
Day High $12.69    P/E N/A 
Day Low $11.57    EPS $ 
Volume 8,030